151 related articles for article (PubMed ID: 34813523)
1. Coronavirus disease 2019 in immunocompromised patients: a comprehensive review of coronavirus disease 2019 in hematopoietic stem cell recipients.
Lafarge A; Mabrouki A; Yvin E; Bredin S; Binois Y; Clere-Jehl R; Azoulay E
Curr Opin Crit Care; 2022 Feb; 28(1):83-89. PubMed ID: 34813523
[TBL] [Abstract][Full Text] [Related]
2. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
3. [COVID-19 vaccination for allogeneic hematopoietic stem cell recipients].
Nagafuji K
Rinsho Ketsueki; 2022; 63(9):1067-1077. PubMed ID: 36198531
[TBL] [Abstract][Full Text] [Related]
4. Severe acute respiratory syndrome coronavirus 2 infection in the stem cell transplant recipient - clinical spectrum and outcome.
Fernández-Ruiz M; Aguado JM
Curr Opin Infect Dis; 2021 Dec; 34(6):654-662. PubMed ID: 34751184
[TBL] [Abstract][Full Text] [Related]
5. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
[TBL] [Abstract][Full Text] [Related]
6. Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.
Shahzad M; Chaudhary SG; Zafar MU; Hassan MA; Hussain A; Ali F; Anwar I; Ahmed M; Ahmed N; Khurana S; Rauf MA; Anwar F; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
Transpl Infect Dis; 2022 Apr; 24(2):e13792. PubMed ID: 35030267
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.
Sharma A; Bhatt NS; St Martin A; Abid MB; Bloomquist J; Chemaly RF; Dandoy C; Gauthier J; Gowda L; Perales MA; Seropian S; Shaw BE; Tuschl EE; Zeidan AM; Riches ML; Shah GL
Lancet Haematol; 2021 Mar; 8(3):e185-e193. PubMed ID: 33482113
[TBL] [Abstract][Full Text] [Related]
8. [Hematopoietic stem cell transplantation during the COVID-19 pandemic with reference to EBMT recommendation].
Atsuta Y; Doki N
Rinsho Ketsueki; 2021; 62(2):106-114. PubMed ID: 33678769
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 in hematopoietic stem-cell transplant recipients: A systematic review and meta-analysis of clinical characteristics and outcomes.
Randi BA; Higashino HR; Silva VPD; Xavier EM; Rocha V; Costa SF
Rev Med Virol; 2023 Nov; 33(6):e2483. PubMed ID: 37794598
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group.
Piñana JL; López-Corral L; Martino R; Montoro J; Vazquez L; Pérez A; Martin-Martin G; Facal-Malvar A; Ferrer E; Pascual MJ; Sanz-Linares G; Gago B; Sanchez-Salinas A; Villalon L; Conesa-Garcia V; Olave MT; López-Jimenez J; Marcos-Corrales S; García-Blázquez M; Garcia-Gutiérrez V; Hernández-Rivas JÁ; Saus A; Espigado I; Alonso C; Hernani R; Solano C; Ferrer-Lores B; Guerreiro M; Ruiz-García M; Muñoz-Bellido JL; Navarro D; Cedillo A; Sureda A;
Am J Hematol; 2022 Jan; 97(1):30-42. PubMed ID: 34695229
[TBL] [Abstract][Full Text] [Related]
11. Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response-a prospective, single-arm study.
Barkhordar M; Chahardouli B; Biglari A; Ahmadvand M; Bahri T; Alaeddini F; Sharifi Aliabadi L; Noorani SS; Bagheri Amiri F; Biglari M; Shemshadi MR; Ghavamzadeh A; Vaezi M
Front Immunol; 2023; 14():1169666. PubMed ID: 37153556
[TBL] [Abstract][Full Text] [Related]
12. Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases.
Greco R; Snowden JA; Knelange NS; Tridello G; Cacciatore C; Xhaard A; Ciceri F; Collin M; Ferra C; De Becker A; Badoglio M; Averbuch D; Alexander T; Ljungman P; De la Camara R;
J Autoimmun; 2023 Apr; 136():103024. PubMed ID: 37001437
[TBL] [Abstract][Full Text] [Related]
13. Immune response to vaccination against SARS-CoV-2 in hematopoietic stem cell transplantation and CAR T-cell therapy recipients.
Wu X; Wang L; Shen L; He L; Tang K
J Hematol Oncol; 2022 Jun; 15(1):81. PubMed ID: 35710431
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
Fabiani S; Fortunato S; Petrini M; Bruschi F
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study.
Bhatt NS; Sharma A; St Martin A; Abid MB; Brown VI; Diaz Perez MA; Frangoul H; Gadalla SM; Herr MM; Krem MM; Lazarus HM; Martens MJ; Mehta PA; Nishihori T; Prestidge T; Pulsipher MA; Rangarajan HG; Williams KM; Winestone LE; Yin DE; Riches ML; Dandoy CE; Auletta JJ
Transplant Cell Ther; 2022 Oct; 28(10):696.e1-696.e7. PubMed ID: 35798233
[TBL] [Abstract][Full Text] [Related]
16. Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.
Busca A; Salmanton-García J; Marchesi F; Farina F; Seval GC; Van Doesum J; De Jonge N; Bahr NC; Maertens J; Meletiadis J; Fracchiolla NS; Weinbergerová B; Verga L; Ráčil Z; Jiménez M; Glenthøj A; Blennow O; Tanase AD; Schönlein M; Prezioso L; Khanna N; Duarte RF; Žák P; Nucci M; Machado M; Kulasekararaj A; Espigado I; De Kort E; Ribera-Santa Susana JM; Marchetti M; Magliano G; Falces-Romero I; Ilhan O; Ammatuna E; Zompi S; Tsirigotis P; Antoniadou A; Zambrotta GPM; Nordlander A; Karlsson LK; Hanakova M; Dragonetti G; Cabirta A; Berg Venemyr C; Gräfe S; Van Praet J; Tragiannidis A; Petzer V; López-García A; Itri F; Groh A; Gavriilaki E; Dargenio M; Rahimli L; Cornely OA; Pagano L
Front Immunol; 2023; 14():1125030. PubMed ID: 36911708
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination.
Piñana JL; Martino R; Vazquez L; López-Corral L; Pérez A; Chorão P; Avendaño-Pita A; Pascual MJ; Sánchez-Salinas A; Sanz-Linares G; Olave MT; Arroyo I; Tormo M; Villalon L; Conesa-Garcia V; Gago B; Terol MJ; Villalba M; Garcia-Gutierrez V; Cabero A; Hernández-Rivas JÁ; Ferrer E; García-Cadenas I; Teruel A; Navarro D; Cedillo Á; Sureda A; Solano C;
Bone Marrow Transplant; 2023 May; 58(5):567-580. PubMed ID: 36854892
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 in HSCT recipients: a collaborative study of the Brazilian Society of Marrow Transplantation (SBTMO).
Daudt LE; Corso MCM; Kerbauy MN; de Assis LHDS; Rechenmacher C; Colturato I; Barbieri FR; Rocha V; Mariano L; Garcia JL; Dantas VECB; Loth G; Funke VAM; Pelegrina PRD; Duarte FB; da Silva RL; Araújo MAS; Carlesse FAMC; de Sousa AVL; Maia LA; Fernandes JF; Rodrigues CA; Bonfim C; Martins LNGF; Cipolotti R; Xavier EM; Gomes AA; Morales HMP; Simioni AJ; Soares VJ; Michalowski MB; Hamerschlak N; Machado CM
Bone Marrow Transplant; 2022 Mar; 57(3):453-459. PubMed ID: 35027676
[TBL] [Abstract][Full Text] [Related]
19. Surveillance and Outcomes of Pediatric Hematopoietic Stem Cell Transplantation Recipients During the Recent COVID-19 Outbreak in China.
Wang X; Yu U; Ding C; Ye H; Wang C; Yang C; Li Y; Zhou X; Zhang Q; Liu S; Wen F
Infect Drug Resist; 2023; 16():7455-7464. PubMed ID: 38089959
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid does not reduce SARS-CoV-2 infection in newly allogeneic hematopoietic stem cell transplantation recipients: a prospective NICHE cohort.
Gao H; Wang J; Zheng X; Pei X; Zheng Y; Zhai W; Zhang R; Chen X; Ma Q; Wei J; Yang D; Pang A; He Y; Feng S; Cao Y; Jiang E
Front Cell Infect Microbiol; 2024; 14():1324019. PubMed ID: 38505288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
